EUVIMEDEUVIMED entdecken
Multizentrische Studie

The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation

Jason Anthony Trubiano iD, Sara Vogrin, Elise Mitri, Rebecca Hall, Ana Copaescu, Jamie Waldron, Joseph De Luca, Morgan Rose, Geoff Mackay, Belinda Lambros, Abby P Douglas, Natasha E Holmes und 1 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad156 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Jason Anthony Trubiano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Hypersensitivity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Better Care Victoria Innovation Fund, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective, multicenter cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityHypersensitivityHumansPenicillinsProspective StudiesInpatientsAnti-Bacterial Agents

Stichwörter der Autor:innen

amoxicillin allergyantimicrobial stewardshipbeta-lactam allergydrug allergyoral provocation

Substanzen

PenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Victoria, Australia.
  • Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Department of Pharmacy, Austin Health, Heidelberg, Victoria, Australia.
  • Department of Medicine, Division of Allergy and Clinical Immunology, McGill University Health Center, Montreal, Quebec, Canada.
  • Department of Infectious Diseases, The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
  • Albury Wodonga Health, Albury, New South Wales, Australia.

ORCID-Profile: Jason Anthony Trubiano

Förderung

  • Better Care Victoria Innovation Fund
  • National Health and Medical Research Council

Zitieren

APA

Trubiano, J. A., Vogrin, S., Mitri, E., Hall, R., Copaescu, A., Waldron, J., De Luca, J., Rose, M., Mackay, G., Lambros, B., Douglas, A. P., Holmes, N. E., & Chua, K. Y. L. (2023). The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad156

Vancouver

Trubiano JA, Vogrin S, Mitri E, Hall R, Copaescu A, Waldron J, et al. The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad156

BibTeX
@article{Trubiano2023,
  author = {Trubiano, Jason Anthony and Vogrin, Sara and Mitri, Elise and Hall, Rebecca and Copaescu, Ana and Waldron, Jamie and De Luca, Joseph and Rose, Morgan and Mackay, Geoff and Lambros, Belinda and Douglas, Abby P and Holmes, Natasha E and Chua, Kyra Y L},
  title = {The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad156}
}
Kostenlos starten →